Christopher Chidiebere
ConDroTech is an online platform that connects oxygen manufacturers, pharmaceuticals and small and large health care centers inorder to access and share health care services and resources.
The pandemic showed us what lack of connectivity in the healthcare service means.
We are solving the problem of healthcare delays, adulterations , quick medical delivery and a platform to connect pharmaceuticals, oxygen manufacturers and helathcare centres inorder to receive quick services and save lives in ample time.
What it does ?
It is a an application platform that connects oxygen manufacturers, pharmaceuticals and medical laboratories in order to quickly access and procure medical resources easily.
We ship and deliver these products when ordered .
Process And Technology?
1. A manufacturer who makes oxygen signs up on the site
2. He delivers his products to be listed on the site.
3. A hospital who needs oxygen sign up and orders for the product.
4. Medical product including any organ, tissue or samole is packaged, automatically stored and delivered on time
Technology?
We make use of solar powered freezing technology to store and AI systems to monitor medical products in the inventory or warehouse.
We also provide on-transit monitoring and preservation of medical product.
My technology will bring the healthcare sector onto the internet by connecting healthcare centres and pharmaceuticals, including oxygen manufacturers..
This product serves the general public as health is everyone's business but how fast resources move in the healthcare sector is our problem.
The pandemic was a reminder of how left out the healthcare sector has been on connectivity and haste decision making and moving of resources. This lack of innovation has caused precious lives to be lost.
My team is made of three , including a computer Scientist and web developer, a medical laboratory scientist and a nurse .
We have worked together in different community services partnering to health and it was during this time that we discovered the need for a centralized system in the healthcare sector.
Currently we have brought this solution to three health executive who have looked at how project and have given it a go ahead.
We have gathered resources and have engaged potential user to contribute on the product design
- Improving healthcare access and health outcomes; and reducing and ultimately eliminating health disparities (Health)
- Concept: An idea being explored for its feasibility to build a product, service, or business model based on that idea.
The market value of the Health care technology is currently at 10billion dollar with an available market of about 600 billion dollars in the next 3 years.
My solution is set to disrupt this market with it's uniqueness as the solution which it provides is lacking and in serious need.
Patients often avoid buying good medicine s due to high cost.
Our goal is to re-invest some of our profits into the products inorder to lower the price of meds.
Our technology include software and IoTs.
Our software is an health commerce website powered with cloud technology.
Our warehouses will rely on renewable energy sources to help reduce carbon footprint
Our IoT devices will be used to monitor and control the temperature of our products during storage and delivery.
- Artificial Intelligence / Machine Learning
- Internet of Things
- Software and Mobile Applications
- Nigeria
We plan to serve about 3 million to 7 million people in the next five years and rapidly increase at about 49.7% annually.
Our main barrier has been the lack of funds.
This is our greatest barrier.
We have not yet made a collaboration.
Our target collaborations will be logistics and drone companies once our solution is launched.
Getting to our customers will be easy through Ad campaigns.
The covid pandemic was a reminder that the healthcare sector needed an overhaul and connection both in medical practice and suppliers.
This is the huge gap we're going to feel and bring change to the system.
Financial sustainability will include free grants from NGOs, personal funds and venture capital.